Carlson Matthew L, Patel Neil S, Glasgow Amy E, Habermann Elizabeth B, Grossardt Brandon R, Link Michael J
Department of Otolaryngology-Head and Neck Surgery, Mayo Clinic, 200 First St SW, Rochester, MN, 55905, USA.
Department of Neurologic Surgery, Mayo Clinic, 200 First St SW, Rochester, MN, 55905, USA.
J Neurooncol. 2016 May;128(1):101-108. doi: 10.1007/s11060-016-2082-4. Epub 2016 Feb 22.
Over the years the authors have evaluated a number of patients with vestibular schwannomas (VS) who have also been diagnosed with a pituitary adenoma (PA). No associations between these tumors have been established to date. The objective of the current study is to investigate the epidemiological association between VS and PA via a population-based study and to supplement these data with a retrospective case series of 12 patients who were evaluated at the authors' center over the past 15 years. An analysis of the Surveillance, Epidemiology, and End Results database including all patients identified with a diagnosis of VS and/or PA was performed. A comparison between the observed and expected annual incidence was calculated and population differences between those with VS + PA were compared with single tumor populations. 9888 patients with VS and 26,577 patients with PA were identified among 822.9 million person-years. Within these populations, 31 patients were diagnosed with both tumor types. Overall, 1 in every 319 patients with VS was also diagnosed with a PA. The average annual incidence for VS was 1.2 per 100,000 persons per year while the average PA rate was 3.2 per 100,000 persons per year. The observed rate of co-incident VS and PA was greater than what is expected by chance alone assuming independence. The cohort of patients with coexisting VS and PA were older and more commonly male compared to VS-only or PA-only groups. These data strongly suggest that a common environmental or genetic predisposition exists for VS and PA development. Further study of this population may help elucidate the cause of tumorigenesis in a subset of patients with seemingly sporadic tumors.
多年来,作者评估了许多同时被诊断患有前庭神经鞘瘤(VS)和垂体腺瘤(PA)的患者。迄今为止,尚未确定这些肿瘤之间存在关联。本研究的目的是通过一项基于人群的研究来调查VS和PA之间的流行病学关联,并通过回顾性病例系列补充这些数据,该病例系列包括过去15年在作者所在中心接受评估的12名患者。对监测、流行病学和最终结果数据库进行了分析,纳入了所有确诊为VS和/或PA的患者。计算了观察到的年发病率与预期年发病率之间的比较,并将VS + PA患者与单一肿瘤患者群体的人群差异进行了比较。在8.229亿人年中,共识别出9888例VS患者和26577例PA患者。在这些人群中,有31例患者被诊断患有这两种肿瘤类型。总体而言,每319例VS患者中就有1例也被诊断患有PA。VS的平均年发病率为每年每10万人1.2例,而PA的平均发病率为每年每10万人3.2例。假设独立,观察到的VS和PA同时发生的比率高于仅由偶然因素预期的比率。与仅患有VS或仅患有PA的组相比,同时患有VS和PA的患者队列年龄更大,男性更常见。这些数据强烈表明,VS和PA的发生存在共同的环境或遗传易感性。对这一人群的进一步研究可能有助于阐明一部分看似散发性肿瘤患者的肿瘤发生原因。